homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


Subscriber content preview

August 13, 2020

Race is on to test COVID antibody drugs

  • These drugs could give quick, temporary immunity to people at high risk of infection, and are also being tested as treatments.
    • By MARILYNN MARCHIONE
    AP Chief Medical Writer

    With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.

    Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there's an infection so it makes antibodies and remembers how to do that if the real bug turns up.


     
    . . .


    To read this story in full login or purchase a subscription.



    
    Email or user name:
    Password:
     
    Forgot password? Click here.